Review Article

An Overview on Pathophysiology of Premenstrual Syndrome

Minu Johny¹, Archana Rajagopalan², Kumar Sai Sailesh¹, Srilatha Basetti³ and Mukkadan Joseph Kurien⁴*

¹Department of Physiology, Little Flower Institute of Medical Sciences and Research, India

²Department of physiology, Saveetha Medical College, India

³Department of Biochemistry, Apollo Institute of Medical Sciences and Research, India

⁴Department of Research, Little Flower Medical Research Centre, India

Submission: March 22, 2017; Published: April 04, 2017

*Corresponding author: Mukkadan Joseph Kurien, Professor & Research Director, Little Flower Medical Research Centre, Angamaly, Kerala, India, Email: saisailesh.kumar@gmail.com

How to cite this article: Minu J, Archana R, Kumar S S, Srilatha B, Mukkadan J K. An Overview on Pathophysiology of Premenstrual Syndrome. Anatomy Physiol Biochem Int J. 2017; 2(1): 555580.DOI:10.19080/APBIJ.2017.02.555580

Abstract

Premenstrual disorder (PMS) is described by the cyclic way of a gathering of mental, physiological, or potentially behavioral side effects showing up amid the late luteal period of the menstrual cycle i.e. 7 to 14 days prior to menstruation and as a rule vanishing not long after the onset of menses. The present article presents causes, pathophysiology of somatic symptom and available management methods for premenstrual syndrome, which helps to understand PMS and also to plan further research for new, effective management methods.

Keywords: Premenstrual syndrome; Pathophysiology; Management methods

Abbreviation: PMS: Pre-Menstrual disorder; PMT: Premenstrual Tension; GABA: γ-Amino-Butyric corrosive; NSAIDs: Non-Steroidal AntiInflammatory Drugs; SSRIs: Specific Serotonin Reuptake Inhibitors; OCs: Oral Contraceptives; PMS-H: Pre-Menstrual indications of fluid Support

Introduction

Premenstrual disorder (PMS) is described by the cyclic way of a gathering of mental, physiological, or potentially behavioral side effects showing up amid the late luteal period of the menstrual cycle i.e. 7 to 14 days prior to menstruation and as a rule vanishing not long after the onset of menses [1]. It is at first depicted as Premenstrual Tension (PMT), showed up in the biomedical writing in 1931 by Robert Frank. He expressed that PMT happened in ladies who "whine of a sentiment unbelievable strain from10 to seven days going before monthly cycle, which in many examples proceeds until the time that the menstrual stream happens. These patients grumble of turmoil, peevishness, "for example, ricocheting out of their and skin"and a yearning to find help by absurd and ill considered activities" (1931: 1054). Two restorative professionals, Raymond Greene and Katharina Dalton (1953: lOO8), renamed the gathering of indications "premenstrual disorder" because of their perception that strain was just a single of the numerous segment of the disorder.

Definition of PMS

The puzzling way of PMS can be found in the definitional rules settled upon by representatives to an interdisciplinary gathering in 1984: Premenstrual disorder (PMS) can be characterized as the event of gently to-seriously troublesome physical and additionally mental side effects, intermittent in relationship with the premenstrual period of the menstrual cycle. Additionally depicting highlights include: degree of useful disturbance made by indications; level of flexibility from side effects amid the postmenstrual benchmark period; and the level of responsiveness to particular etiologically-derived ameliorative measures [2].

Causes of PMS

In spite of impressive research, the correct reasons for PMS are not completely caught on. While PMS is connected to the luteal stage, estimations of sex hormone levels are within distinctive level. PMS has a tendency to be more normal among twins, recommending the likelihood of some hereditary part. Current deduction presumes that focal sensory system neurotransmitter collaboration with sex hormones is impacted. It is thought to be connected to the action of serotonin (a neurotransmitter) in the brain [3]. It has been hypothesized that it speaks to a disorder which is the consequence of numerous biochemical irregularities.

Amongst these following have been implicated:

1. Hormonal changes such as Oestrogen excess or progesterone deficiency in the luteal phase,
2. Increased carbohydrate tolerance in the luteal phase,
3. Pyridoxine deficiency,
4. Increased production of vasopressin, aldosterone,
5. Fluctuation in opiate peptide concentrations affecting endorphin levels.
6. vi. Eating habits, drugs and life styles

However biochemical estimations don't bear this out. Hence at present it is not yet clear whether PMS is a strange reaction to ordinary hormonal vacillation or an after effect of hormonal abnormalities [4,5]. In this specific circumstance, one ought to consider the way that, generally, rehashed pregnancies, lactation or malnourishment prompted to broadened times of amenorrhea, a circumstance that has changed by advances in nourishment and with our capacity to manage procreation [6]. The result is that women today have any more extended circumstances of cyclic differences of progesterone and estrogen with related premenstrual symptoms [6]. Many specialists propose that premenstrual grievances are inspired by the drop in progesterone focuses in the late luteal stage that may lead to the changes in CNS neurotransmitters, for example, y-aminobutyric corrosive (GABA) [7,8]. This hypothesis is, however tested by the way that numerous women have indications that begin at ovulation and amid the early luteal stage-i.e. before the fall in progesterone has begun.

The cerebrum neurotransmitter serotonin is involved in the direction of mind-set and conduct, incompletely as a result of perceptions made in preclinical reviews and halfway due to the energizer and nervousness diminishing impacts applied by serotonin-encouraging medications in people. In the USA the significant perspective was that liquid maintenance (the consequence of hormones) was the prompt reason for premenstrual issues. This appears to have created from Frank's unique depiction of premenstrual strain in 1931. Straight to the point prescribed ousting the overabundance hormones through pee and excrement with the assistance of different diuretic substances. In American therapeutic diaries in the 1950s diuretic treatment kept on being suggested even after the hypothesis of abundance oestrogen had been rejected [9,10]. In Britain, it was the work of the British doctor Katharina Dalton that formed the early etiology and treatment method of reasoning. Starting in the 1950s, PMS Occurred as an insufficiency of progesterone that could be settled by hormone substitution treatment utilizing common progesterone [11]. French analysts in this period at first trusted that an overabundance of estrogen was the wellspring of premenstrual issues and considered water maintenance essential in the symptomatology of PMS [12].

Clinical Features of PMS

Symptoms of PMS fall into three domains: emotional, physical, and behavioral changes that presented premenstrually and resolve gradually following the cessation of menstrual bleeding. Emotional symptoms include depression, irritability, tension, crying, over sensitivity (hypersensitivity) and mood swings with alternating sadness and anger. Physical signs and symptoms may include headache, fatigue, weight gain, abdominal bloating, and breast tenderness. Behavioral symptoms include food cravings, poor concentration, social withdrawal, forgetfulness and decreased motivation [13]. However some may have pain in abdomen with or without gastrointestinal upsets like anorexia and vomiting. The medical and social consequences of premenstrual symptoms and disorders of menstruation influence not only the individual but also her family and society [14,15].

A study revealed the following symptoms:

1. marked depressive mood, feeling of hopelessness or self depreciation thoughts -77.7%
2. ii. difficulty of concentration -65.8%
3. marked change in appetite ,over eating or specific food craving -82.8 %
4. affective labiality ,with sadness tearful and increased sensitivity to rejection 65.8%
5. hypersomnia or insomnia 59.7%
6. lethargy, excessive fatigability -91.6%
7. breast tenderness, swelling headache joint muscular pain and a sensation of bloating and weight gain 81.9%
8. the most severe symptoms were fatigue and irritability-73.9% 15

The length of symptom and its expression varies, may lasts for a few days to 2 weeks. Symptoms often worsen substantially 6 days before and peak at about 2 days before the onset of menses and subside at the onset or after several days of menstruation [16,17]. A few examples of genuine or evident comorbidity can happen in a woman with premenstrual side effects. To begin with, co-occurrence of disorders at different peak of life (life time comorbidity). Second, she may have continuous psychiatric and simultaneous premenstrual side effects that are not part of the co-happening clutter (simultaneous comorbidity). Third, she may have a progressing psychiatric or general restorative condition that turns out to be more terrible premenstrually- typically characterized as premenstrual exacerbation [18,19]. Nervousness issue likewise happen at a higher rate in women with PMS. Women with PMS, similar to those with frenzy issue (however rather than those with other inclination issue), have an expanded propensity to frenzy when presented to panicogenic specialists and PMS share certain pathophysiological mechanisms [20,21].

Pathophysiology of Somatic Symptoms of PMS

It stays misty whether premenstrual substantial indications, like bosom delicacy, bloating, and joint and muscle torment- result from lessened resilience to physical uneasiness while in a dysphoric temperament state or are created by changes in hormone-responsive tissues in the fringe. Examiners have abandoned to affirm liquid maintenance or bosom broadening in women detailing these symptoms, [22,23] in addition, management went for influencing mind neurotransmission- eg, the SRIs-applies in any occasion some palliative effect on significant reactions. Then again, the dopamine D2 receptor agonist, bromocriptine, [24,25] or chasteberry, which bring down serum convergences of prolactin, are compelling for the treatment of premenstrual mastalgia, yet not for disposition manifestations. In like manner, a particular impact on premenstrual mastalgia could be accomplished by luteal organization of danazol 105 or an estrogen-receptor antagonist [26].

Aftereffects of some early reviews recommend the association of aldosterone or deoxycorticosterone, a progesterone metabolite and aldosterone agonist, [27] in the pathophysiology of premenstrual bloating. Given that serious stomach bloating happens without weight increase, any hypothesis identified with water maintenance is, notwithstanding, hooked on doubt. Many trust that premenstrual cerebral pain, headache and epilepsy ought not to be viewed as a feature of PMS, but rather as independent conditions. Strikingly, SRIs have no impact on premenstrual cerebral pain. Difficult menstrual dying (dysmenorrhoea), endometriosis and menopausal manifestations are regularly mistaken as PMS [28].

Diagnosis

According to the "Diagnostic and Statistical Manual of Mental Disorders", 4^th edition of the American Psychiatric Association [19]. Washington, DC has defined the criteria for PMDD. To full fill the diagnostic criteria a patient needs to present five or more distressing symptoms during the luteal phase and at least one of these symptoms have to be mood symptoms. The cardinal symptoms are:

1. Irritability
2. Depressed mood
3. Affect lability

PMS might be a socially constructed disorder and PMS is a collection of symptoms. More than 200 different symptoms have been identified but three most prominent symptoms are irritability, tension and dissatisfaction with life Rodin et al. [29] DSM-IV Research Criteria for PMS [29] in most menstrual cycles in the midst of the earlier year, (not less than five) of the going with symptoms were accessible for usually in the middle of the latest week of the luteal stage, begin to transmit inside a few days after the onset of the follicular stage, and were absent in the week post menses, with no short of what one of the signs.

The signs include:

1. Markedly discouraged state of mind, sentiments of sadness, or self-censuring considerations.
2. Marked uneasiness, strain, sentiments of being "keyed up" or "anxious"
3. Marked influenced risk (e.g. feeling all of a sudden tragic or mournful or expanded affectability to dismissal)
4. Persistent and stamped outrage or fractiousness or expanded interpersonal clashes.
5. Decreased enthusiasm for normal exercises (e.g. work, schools, companions, side interests)
6. Subjective feeling of trouble in concentrating.
7. Lethargy, simple fatigability, or checked absence of vitality.
8. Marked change in hunger, over eating, or particular sustenance needing.
9. Marked hypersomnia or sleep deprivation.
10. A subjective feeling of overpowered or crazy.
11. Other physical manifestations, for example, bosom delicacy or swelling, or migraines, joint or muscle torment, an impression of "bloating", weight pick up.

Prevalence of PMS in India

It was revealed that 58% has symptom of PMS on certain occasion and 42% once in a while. In India considers reveal that 20% of them continue PMS in which 8% have outrageous signs. Likewise reports demonstrated that suicide goals existed with around 10% [4]. A review directed at Gujarat appears the predominance of PMS was 18.4%. Direct to serious PMS was 14.7% and PMDD was 3.7% as indicated by DSM IV-TR and 91% as per International Classification of Diseases, tenth release criteria [30].

Prevalence of PMS in World

PMS manifestations are high similar to very nearly 80-90% in which 5% are women who endure extremely and it affect their daily routine. 25% of immature young women experienced PMS and PMS among profoundly instructed women are normal and expanded plausibility of worry with PMS is likewise observed. Commonness of PMS substantially more in age gathering of 15-49 years (5.9-90% among this age assemble) and between 90% of the women everywhere throughout the world including Pakistan, encounter these indications amid at their reproductive age [31] It has been assessed from review group overviews that almost 90% of women have encountered no less than one premenstrual disorder. Epidemiological studies have evaluated that upwards of 75% of regenerative age women encounter a few manifestations ascribed to the premenstrual period of menstrual cycle [32].

A study has been done in Tehran among 320 female Teacher training University showed that the prevalence of PMDD was 16.9%. The most common physical symptom was abdominal cramp 75.3% and mental symptom was tiredness 70.3%. The least common symptom was short breath 1.3%. In this study, nearly 50% of students with PMS took drugs for decreasing their symptoms. Although, most of the Iranian women take herbal drugs for relieving symptoms [33]. A cross sectional descriptive survey was conducted in Thailand among 266 female students of Assumption University, Bangkok. According to the data, more than 98% of the respondents indicated one or more PMS symptoms. However, only 28% reported feeling of PMS symptoms before every period. When the respondents noticed PMS symptoms, 41.4% used paracetamol, 24.4% used Ponstan and 3.4% used Advil. Other non-pharmacologic treatments were sleep (75.9%), exercise (23%), and dietary change (10%) [34].

Pharmacological Treatment

PMS administration incorporates pharmacological and non pharmacological measures. Pharmacological administration incorporates diuretics, prostaglandin inhibitors and progesterone inhibitors, ovulation inhibitors, antidepressants and vitamins. Current treatment alternatives incorporate nonsteroidal anti-inflammatory drugs (NSAIDs) (for dysmenorrhea), specific serotonin reuptake inhibitors (SSRIs), and ovulation concealment (e.g., with oral contraceptives). Treatment with oral contraceptives (OCs), especially broadened or ceaseless utilize, may fundamentally decrease the occurrence of menstrual cycle-related indications [35].

Non Pharmacological Treatment

Non pharmacological or way of life measures incorporate work out, yoga, stress administration, dynamic muscle unwinding, connection abilities, self improvement, gatherings and exercise. Pharmacological therapy can be started if these measures are failed [36].

Lifestyle Modification

Way of life adjustments for the treatment of PMS incorporate dietary changes, work out, subjective behavioral treatments, and reciprocal and option drug, and might be all that is important to reduce gentle to-direct manifestations. Dietary suggestions incorporate premenstrual declines in caffeine, salt, and refined sugars and littler, more continuous dinners to help reduce crabbiness, a sleeping disorder, liquid maintenance, bosom delicacy, bloating, and weight gain. Cognitive behavioral treatment, counting loosening up and rest cleanliness, maybe feasible treatment for physical and energetic premenstrual indications and is best in ladies with genuine side effects [37].

Complementary therapy to treat PMS

Vitamin B6 is frequently used to treat premenstrual disorder without clear confirmation of its viability. The prescribed dietary recompense for Vitamin B6 is around 2.0mg/day and lack of Vitamin B6 is uncommon. Because of the doubtful viability of Vita-min B6 in treating premenstrual disorder, a systematic audit of distributed and unpublished randomized fake treatment controlled trials of ampleness of Vitamin B6 in the organization of premenstrual issue has been grasped. This showed a unimportant preferred standpoint for using Vitamin B6. There is no purpose behind giving step by step estimations of Vitamin B6 in excess of 100mg, especially taking after suggestion from the Department of Health and the Medicine Control Agency in 1999 to limiting the measurements of Vitamin B6 open all around to 10mg and to confine the dose sold by a medication expert to under 50mg [38].

Magnesium

Preliminary small studies suggest that magnesium may also be helpful in PMS. A low-measurements every day supplement of 200 mg of MgO by and large diminished smooth premenstrual indications of fluid support (PMS-H) in women persevering premenstrual appearances in the second cycle of supplementation, however not in the midst of the principal cycle, differentiated and fake healing [39].

Vitamin D

Studies shows that blood calcium and Vitamin D levels are lower in women with PMS and that calcium supplementation may diminish manifestation severity, yet it is obscure whether this may keep the underlying advancement of PMS. Calcium supplementation diminish early fatigability, changes in craving, and wretchedness in women with PMS [40].

Hormonal Therapy

A current meta-examination of all distributed reviews for progestogen and progesterone treatment of PMS. The goal of this orderly audit was to assess the adequacy of genius progesterone and progestogens in the administration of premenstrual disorder. Each one on the trials of progesterone (by both courses of association) showed no clinically critical complexity among progesterone and fake treatment The use of progesterone or progestogens in the administration of premenstrual disorder is not effective [41].

Surgical Treatment

In serious manifestations the patient does not wish to have kids, an aggregate abdominal hysterectomy with respective oophorectomy joined by fitting hormone substitution treatment can be a to a great degree powerful and all around acknowledged perpetual cure for PMS [42].

Conclusion

The present article presents causes, pathophysiology of somatic symptom and available management methods for premenstrual syndrome, which helps to understand PMS and also to plan further research for new, effective management methods.

References

1. Kumar Sai Sailesh, Archana R, Mukkadan JK (2014) Controlled vestibular stimulation: A Traditional Intervention for Pre-menstrual Syndrome. J Clin Biomed Sci 4(4): 362.
2. Preeti Garg , Prithpal S Matreja, Prem P Khosla , Lovepreet Kaur , Praveen Mohan (2014) Correlation of symptoms of premenstrual syndrome in Indian set-up. American Journal of Health Research 2(3): 102-105.
3. Knaapen L, Weisz G (2008) The biomedical standardization of premenstrual syndrome. Stud Hist Philos Biol Biomed Sci 39(1): 120134.
4. Matsumoto T, Ushiroyama T, Kimura T, Hayashi T, Moritani T (2007) Altered autonomic nervous system activity as a potential etiological factor of premenstrual syndrome and premenstrual dysphoric disorder. Biopsychosoc Med 1: 24.
5. Dawn CS (2003) Text book of Gynaecology and Contraception. (7^th edn), Sri KK Ray. Navana Printing Works Pvt Ltd, pp. 172.
6. Ginsburg B, B Carter (1987) Premenstrual Syndrome. Ethical and Legal implications in a Biomedical Perspective, Plenum Press, New York, USA.
7. MacDonald PC, Dombroski RA, Casey ML (1991) Recurrent secretion of progesterone in large amounts:An endocrine/metabolic disorder unique to young women? Endocr Rev 12(4): 372-401.
8. Smith SS, Ruderman Y, Frye C, Homanics G, Yuan M (2006) Steroid withdrawal in the mouse results in anxiogenic effects of 3alpha, 5beta-THP: a possible model of premenstrual dysphoric disorder. Psychopharmacology 186(3): 323-333.
9. Sundstrom Poromaa I, Smith S, Gulinello M (2003) GABA receptors, progesterone and premenstrual dysphoric disorder. Arch Women Ment Health 6(1): 23-41.
10. Bickers W (1952) Premenstrual tension and its relationship to water metabolism. Am J Obstet Gynecol 64(3): 587-590.
11. Behrman SJ, Buxton CL (1961) Premenstrual tension. American Journal of Obstetrics and Gynecology 81: 606-609.
12. Greene R, Dalton K (1953) The premenstrual syndrome. British Medical Journal 1(4818): 1007-1014.
13. Shruti Brahmbhatt, BM Sattigeri, Heena Shah, Ashok Kumar, Devang Parikh (2013) A prospective survey study on premenstrual syndrome in young and middle aged women with an emphasis on its management. Int J Res Med Sci 1(2): 69-72.
14. G J Tortora, B H Derrickson. Principles of anatomy & physiology. (10^th edn), John Wiley & sons publication, USA, 2003: 1053.
15. Deepali S Deo, Ghattagri CH (2007) Menstrual problems in adolescent school girls: A comparative study in urban and rural area. Indian Journal of preventive and social medicine 38(1-2): 64-68.
16. Silber T J, Valadez-Meltzer A (2005) Premenstrual dysphoric disorder in adolescents case reports of treatment with fluoxetine and review of the literature. J Adolesc Health 37(6): 518-525.
17. Pearlstein T, Yonkers K, Fayyad R, Gillespie J (2005) Pretreatment pattern of symptom expression in premenstrual dsyphoric disorder. J Affect Disord 85(3): 275-282.
18. Meaden PM, Hartlage SA, Cook-Kerr J (2005) Timing and severity of symptoms associated with the menstrual cycle in a community-based sample in the Midwestern United States. Psychiatr Res 134(1): 27-36.
19. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders-DSM-IV. (4^th edn), American Psychiatric Association, Washington, USA.
20. Steiner M, Born L (2000) Diagnosis and treatment of premenstrual dysphoric disorder: an update. Int Clin Psychopharmacol 15 (suppl 3): S5-17.
21. Landen M, Eriksson E (2003) How does premenstrual dysphoric disorder relate to depression and anxiety disorders? Depress Anxiety 17(3): 122-129.
22. Yonkers KA (1997) Anxiety symptoms and anxiety disorders: How are they related to premenstrual disorders? J Clin Psychiatry 58: 62-67.
23. Faratian B, Gaspar A, O'Brien PM, Johnson IR, Filshie GM, et al. (1984) Premenstrual syndrome: weight, abdominal swelling, and perceived body image. Am J Obstet Gynecol 150(2): 200-204.
24. Andersch B, Hahn L, Andersson M, Isaksson B (1978) Body water and weight in patients with premenstrual tension. Br J Obstet Gynaecol 85(7): 546-550.
25. Andersch B (1983) Bromocriptine and premenstrual symptoms: a survey of double blind trials. Obstet Gynecol Surv 38(11): 643-646.
26. Ylostalo P, Kauppila A, Puolakka J, Ronnberg L, Janne O (1981) Bromocriptine and norethisterone in the treatment of premenstrual syndrome. Obstet Gynecol 59(3): 292-298.
27. Oksa S, Luukkaala T, Maenpaa J (2006) Toremifene for premenstrual mastalgia: a randomised, placebocontrolled crossover study. BJOG 113(6): 713-718.
28. O'Brien PM, Craven D, Selby C, Symonds EM (1979) Treatment of premenstrual syndrome by spironolactone. Br J Obstet Gynaeco 86(2): 142-147.
29. Bancroft J, Rennie D (1995) Perimenstrual depression: its relationship to pain, bleeding, and previous history of depression. Psychosom Med 57(5): 445-452.
30. Ghanbari Z, Haghollahi F, Shariat M, Foroshani AR, Ashrafi M (2009) Effects of calcium supplement therapy in Women with premenstrual syndrome. Taiwan J Obstet Gynecol 48 (2): 124-129.
31. Raval CM, Panchal BN, Tiwari DS, Vala AU, Bhatt RB (2016) Prevalence of premenstrual syndrome and premenstrual dysphoric disorder among college students of Bhavnagar, Gujarat. Indian J Psychiatry 58(2): 164-170.
32. Tolossa FW, Bekele ML (2014) Prevalence, impacts and medical managements of premenstrual syndrome among female students: cross-sectional study in college of health sciences, Mekelle University, Mekelle, Northern Ethiopia. BMC Womens Health 14: 52.
33. Nourjah Parvaneh (2008) Premenstrual syndrome among Teacher Training University students in Iran. Journal of Obstetrics & Gynecology of India 58(1): 49-51.
34. Thu Myint, Ore-Giron Edessa, Sawhsarkapaw (2006) Premenstrual Syndrome among Female University students in Thailand. AU JT 9(3): 158-162.
35. Parthasarathy A (2000) IAP Textbook of Community. 1^st edition. Jaypee brothers publication, Delhi, India, pp. 688-693.
36. Kaplan & Sadock's .Synopsis of Psychiatry Behavioral Sciences / Clinical Psychiatry. 8^th Edition, Suite 5025 Media publication, USA, pp. 528.
37. Marriam Zaka, Khawaja Tahir Mahmood (2012) Pre-menstrual syndrome- a review. J Pharm Sci & Res 4(1): 1684-1691.
38. Clayton AH (2008) Symptoms related to the menstrual cycle: diagnosis, prevalence and treatment. J Psychiatr Pract 14(1): 13-21.
39. Doll H, Brown S, Thurston A, Vessey M (1989) Pyridoxine (vitamin b6) and the premenstrual Syndrome: a randomized crossover trial. J R Coll Gen Pract 39(326): 364-368.
40. Walker AF, De Souza MC, Vickers MF, Abeyasekera S, Collins ML, et 42. Cronje WH, Vashisht A, Studd JW (2004) Hysterectomy and bilateral al. (1998) Magnesium supplementation alleviates premenstrual oophorectomy for severe premenstrual syndrome. Hum Reprod 19(9): Symptoms of fluid retention. J Womens Health 7(9): 1157-1165. 2152-2155.
41. Wyatt K, Dimmock P, Jones P, Obhrai M, O'Brien S (2001) Efficacy of progesterone and progestogens in Management of premenstrual syndrome: systematic review. BMJ 323: 776-780.
42. Cronje WH, Vashisht A, Studd JW (2004) Hysterectomy and bilateral oophorectomy for severe premenstrual syndrome. Hum Reprod 19(9):2152-2155.